ID

30864

Beschreibung

Combination Study of Revlimid®, Velcade® Dexamethasone and Doxil® (RVDD)for Newly Diagnosed Multiple Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT00724568

Link

https://clinicaltrials.gov/show/NCT00724568

Stichworte

  1. 28.06.18 28.06.18 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

28. Juni 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Multiple Myeloma NCT00724568

Eligibility Multiple Myeloma NCT00724568

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
you will be eligible to participate in this study if you are at least 18 years old and have newly diagnosed multiple myeloma.
Beschreibung

Age | Multiple Myeloma

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0026764
you will have blood tests and other screening tests before you are enrolled and your test results must be within the limits outlined for eligibility to participate in this experimental study.
Beschreibung

Hematologic Tests | Screening test | Test Results Within defined limits Study Protocol

Datentyp

boolean

Alias
UMLS CUI [1]
C0018941
UMLS CUI [2]
C0871311
UMLS CUI [3,1]
C0456984
UMLS CUI [3,2]
C4047968
UMLS CUI [3,3]
C2348563
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
chronic obstructive or chronic restrictive pulmonary disease and cirrhosis.
Beschreibung

Chronic Obstructive Airway Disease | Restrictive lung disease chronic | Liver Cirrhosis

Datentyp

boolean

Alias
UMLS CUI [1]
C0024117
UMLS CUI [2,1]
C0085581
UMLS CUI [2,2]
C0205191
UMLS CUI [3]
C0023890
patient has hypersensitivity to bortezomib, boron or mannitol or any of the components of doxil.
Beschreibung

Hypersensitivity Bortezomib | Hypersensitivity Boron | Mannitol allergy | Hypersensitivity Doxil Component

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C1176309
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0006030
UMLS CUI [3]
C0571922
UMLS CUI [4,1]
C0020517
UMLS CUI [4,2]
C0279284
UMLS CUI [4,3]
C1705248
female subject is pregnant or breast-feeding.
Beschreibung

Pregnancy | Breast Feeding

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
patient has received other investigational drugs with 14 days before
Beschreibung

Investigational New Drugs

Datentyp

boolean

Alias
UMLS CUI [1]
C0013230
uncontrolled diabetes mellitus.
Beschreibung

Diabetic - poor control

Datentyp

boolean

Alias
UMLS CUI [1]
C0421258
hypersensitivity to acyclovir or similar anti-viral drug.
Beschreibung

Aciclovir allergy | Hypersensitivity Antiviral Agents Similar

Datentyp

boolean

Alias
UMLS CUI [1]
C0571297
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0003451
UMLS CUI [2,3]
C2348205
known hiv infection.
Beschreibung

HIV Infection

Datentyp

boolean

Alias
UMLS CUI [1]
C0019693
known active hepatitis b or c viral infection.
Beschreibung

Hepatitis B | Hepatitis C

Datentyp

boolean

Alias
UMLS CUI [1]
C0019163
UMLS CUI [2]
C0019196
known intolerance to steroid therapy.
Beschreibung

Intolerance Steroid therapy

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0231199
UMLS CUI [1,2]
C0149783
known hypersensitivity to required prophylactic medications.
Beschreibung

Hypersensitivity Pharmaceutical Preparations Prophylactic treatment

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013227
UMLS CUI [1,3]
C0199176

Ähnliche Modelle

Eligibility Multiple Myeloma NCT00724568

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Age | Multiple Myeloma
Item
you will be eligible to participate in this study if you are at least 18 years old and have newly diagnosed multiple myeloma.
boolean
C0001779 (UMLS CUI [1])
C0026764 (UMLS CUI [2])
Hematologic Tests | Screening test | Test Results Within defined limits Study Protocol
Item
you will have blood tests and other screening tests before you are enrolled and your test results must be within the limits outlined for eligibility to participate in this experimental study.
boolean
C0018941 (UMLS CUI [1])
C0871311 (UMLS CUI [2])
C0456984 (UMLS CUI [3,1])
C4047968 (UMLS CUI [3,2])
C2348563 (UMLS CUI [3,3])
Item Group
C0680251 (UMLS CUI)
Chronic Obstructive Airway Disease | Restrictive lung disease chronic | Liver Cirrhosis
Item
chronic obstructive or chronic restrictive pulmonary disease and cirrhosis.
boolean
C0024117 (UMLS CUI [1])
C0085581 (UMLS CUI [2,1])
C0205191 (UMLS CUI [2,2])
C0023890 (UMLS CUI [3])
Hypersensitivity Bortezomib | Hypersensitivity Boron | Mannitol allergy | Hypersensitivity Doxil Component
Item
patient has hypersensitivity to bortezomib, boron or mannitol or any of the components of doxil.
boolean
C0020517 (UMLS CUI [1,1])
C1176309 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0006030 (UMLS CUI [2,2])
C0571922 (UMLS CUI [3])
C0020517 (UMLS CUI [4,1])
C0279284 (UMLS CUI [4,2])
C1705248 (UMLS CUI [4,3])
Pregnancy | Breast Feeding
Item
female subject is pregnant or breast-feeding.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Investigational New Drugs
Item
patient has received other investigational drugs with 14 days before
boolean
C0013230 (UMLS CUI [1])
Diabetic - poor control
Item
uncontrolled diabetes mellitus.
boolean
C0421258 (UMLS CUI [1])
Aciclovir allergy | Hypersensitivity Antiviral Agents Similar
Item
hypersensitivity to acyclovir or similar anti-viral drug.
boolean
C0571297 (UMLS CUI [1])
C0020517 (UMLS CUI [2,1])
C0003451 (UMLS CUI [2,2])
C2348205 (UMLS CUI [2,3])
HIV Infection
Item
known hiv infection.
boolean
C0019693 (UMLS CUI [1])
Hepatitis B | Hepatitis C
Item
known active hepatitis b or c viral infection.
boolean
C0019163 (UMLS CUI [1])
C0019196 (UMLS CUI [2])
Intolerance Steroid therapy
Item
known intolerance to steroid therapy.
boolean
C0231199 (UMLS CUI [1,1])
C0149783 (UMLS CUI [1,2])
Hypersensitivity Pharmaceutical Preparations Prophylactic treatment
Item
known hypersensitivity to required prophylactic medications.
boolean
C0020517 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0199176 (UMLS CUI [1,3])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video